Slow-release fluoride devices: a literature review.
Although the prevalence of caries has decreased dramatically over the past decades, it has become a polarised disease, with most of subjects presenting low caries levels and few individuals accounting for most of the caries affected surfaces. Thus it become evident for the need of clinical approaches directed at these high-risk patients, in order to overcome problems related to compliance and low attendance at dental care centres. Slow-release fluoride devices were developed based on the inverse relationship existing between intra-oral fluoride levels and dental caries experience. The two main types of slow-release devices - copolymer membrane type and glass bead - are addressed in the present review. A substantial number of studies have demonstrated that these devices are effective in raising intra-oral F concentrations at levels able to reduce enamel solubility, resulting in a caries-protective effect. Studies in animals and humans demonstrated that the use of these devices was able to also protect the occlusal surfaces, not normally protected by conventional fluoride regimens. However, retention rates have been shown to be the main problem related to these devices and still requires further improvements. Although the results of these studies are very promising, further randomised clinical trials are needed in order to validate the use of these devices in clinical practice. The concept of continuously providing low levels of intra-oral fluoride has great potential for caries prevention in high caries-risk groups.
Pessan
Juliano Pelim
JP
Department of Paediatric Dentistry and Public Health, Araçatuba Dental School, São Paulo State University, Brazil.
Al-Ibrahim
Nahla Saleh
NS
Buzalaf
Marília Afonso Rabelo
MA
Toumba
Kyriacos Jack
KJ
D000818:Animals; D002327:Cariostatic Agents / Q000008:administration & dosage*; D003731:Dental Caries / Q000517:prevention & control*; D003747:Dental Enamel Solubility / Q000187:drug effects; D016503:Drug Delivery Systems / Q000295:instrumentation*; D017886:Durapatite; D005460:Fluorides, Topical / Q000008:administration & dosage*; D005898:Glass; D006801:Humans; D008567:Membranes, Artificial; D011108:Polymers; D011109:Polymethacrylic Acids
D002327:Cariostatic Agents; D005460:Fluorides, Topical; D008567:Membranes, Artificial; D011108:Polymers; D011109:Polymethacrylic Acids; C038300:methylmethacrylate-methacrylic acid copolymer; D017886:Durapatite